Small cell lung cancer limited stage
Information
- Disease name
- Small cell lung cancer limited stage
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03059667 | Completed | Phase 2 | Immunotherapy as Second-line in Patient With Small Cell Lung Cancer | March 13, 2017 | December 1, 2020 |
| NCT03214003 | Completed | N/A | Twice-daily SIB Radiotherapy Versus Standard Radiotherapy for Patients With SCLC | June 30, 2017 | January 30, 2023 |
| NCT01797159 | Completed | N/A | Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer | March 11, 2013 | March 18, 2019 |
| NCT04602533 | Recruiting | Phase 2 | Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN) | December 21, 2020 | September 30, 2023 |
| NCT05945745 | Recruiting | Molecular Analysis and Treatment Options of SCLC | January 1, 2016 | December 31, 2028 | |
| NCT04418648 | Recruiting | Phase 2 | Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy | June 1, 2020 | May 31, 2024 |
| NCT04543890 | Recruiting | Phase 2 | A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLC | May 1, 2018 | June 1, 2025 |
| NCT05651802 | Recruiting | N/A | PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC Patients | January 1, 2023 | June 2026 |
| NCT04189094 | Unknown status | Phase 2 | Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC | January 1, 2020 | July 1, 2023 |
| NCT04882033 | Unknown status | Phase 1 | Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung Cancer | May 7, 2021 | July 1, 2023 |